Tag Archives: treatment

Hoskin, Warner propose largest mental health investment in tribe’s history | News

[ad_1] Cherokee Nation Principal Chief Chuck Hoskin Jr. and Deputy Chief Bryan Warner are proposing new legislation that would commit over $100 million for addiction treatment facilities, new treatment programs, a scholarship endowment, and other initiatives using settlement funds from the tribe’s opioid and e-cigarette settlements. Hoskin and Warner’s proposal amends the historic Public Health and Wellness Act. The 2021 law, first amended in 2022, already dedicated 7% of third-party health insurance collections to physical and mental wellness programs and locked down $15 million in opioid settlement […]

Read more

Prehabilitation Prior to Breast Cancer Treatment

[ad_1] Researchers investigated whether prehabilitation could yield improvements in physical and psychological wellbeing prior to treatment in women with breast cancer. After systematic review, they concluded that prehabilitation interventions should be implemented in patients diagnosed with breast cancer given the potential improvements they yield. The study’s findings were published in Breast Cancer Research and Therapy. The systematic review was conducted under Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A total of 14 studies on prehabilitation in patients with breast cancer, 7 randomized controlled trials, 5 […]

Read more

Integrating sequential immunotherapy to lung cancer treatment plans

[ad_1] June 24, 2022 1 min watch Source/Disclosures Published by: Source: Healio Interviews Disclosures: Marmarelis reports holding stock and other ownership interests in Bluebird Bio, Gilead Sciences, Johnson & Johnson, Merck, Pfizer and Portola Pharmaceuticals; receiving honoraria from AstraZeneca, Blueprint Medicines, Health Advances, Janssen Oncology, Novocure, Takeda and Targeted Oncology; serving in a consulting or advisory role for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb/Celgene and Ikena Oncology; receiving research funding to Marmarelis’s institution from AstraZeneca, Lilly and Trizell; receiving travel, accommodations and expenses from Boehringer […]

Read more